Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients
Clinical trial NCT02273596 · COMPLETED
Trial details
- NCT number
- NCT02273596
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2016-10-27
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.